Global Cardiopulmonary Autotransfusion System Market Growth 2019-2024

  • receipt Report ID : 179794
  • calendar_today Published On: Jul, 2019
  • file_copy Pages: 136
  • list Medical Devices

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.

The rising prevalence of cardiovascular diseases (CVDs), advancements in technology, and increasing investments in R&D are some of the factors that will propel growth in the cardiopulmonary Autotransfusion systems market in the Americas during the forecast period.

Cardiac surgeries are complex and may result in a significant loss of blood during deep surgical incisions. This can lower the balance of blood in the body and increase the risks of surgery-induced anemia in people after surgery. This leads to the demand for significant volumes of blood supply, which depends on the complexity of the surgery.

According to this study, over the next five years the Cardiopulmonary Autotransfusion System market will register a 2.5% CAGR in terms of revenue, the global market size will reach US$ 590 million by 2024, from US$ 510 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cardiopulmonary Autotransfusion System business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Cardiopulmonary Autotransfusion System market by product type, application, key manufacturers and key regions and countries.

This study considers the Cardiopulmonary Autotransfusion System value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.

Unwashed ATS

Washed ATS

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.

Heart Surgery

Great Organ Transplant Surgery

Other Surgery

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

Haemonetics

Medtronic

LivaNova

Fresenius Kabi

Terumo

Wandong Health Sources

...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Cardiopulmonary Autotransfusion System consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

To understand the structure of Cardiopulmonary Autotransfusion System market by identifying its various subsegments.

Focuses on the key global Cardiopulmonary Autotransfusion System manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Cardiopulmonary Autotransfusion System with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Cardiopulmonary Autotransfusion System submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

2019-2024 Global Cardiopulmonary Autotransfusion System Consumption Market Report

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cardiopulmonary Autotransfusion System Consumption 2014-2024

2.1.2 Cardiopulmonary Autotransfusion System Consumption CAGR by Region

2.2 Cardiopulmonary Autotransfusion System Segment by Type

2.2.1 Unwashed ATS

2.2.2 Washed ATS

2.3 Cardiopulmonary Autotransfusion System Consumption by Type

2.3.1 Global Cardiopulmonary Autotransfusion System Consumption Market Share by Type (2014-2019)

2.3.2 Global Cardiopulmonary Autotransfusion System Revenue and Market Share by Type (2014-2019)

2.3.3 Global Cardiopulmonary Autotransfusion System Sale Price by Type (2014-2019)

2.4 Cardiopulmonary Autotransfusion System Segment by Application

2.4.1 Heart Surgery

2.4.2 Great Organ Transplant Surgery

2.4.3 Other Surgery

2.5 Cardiopulmonary Autotransfusion System Consumption by Application

2.5.1 Global Cardiopulmonary Autotransfusion System Consumption Market Share by Application (2014-2019)

2.5.2 Global Cardiopulmonary Autotransfusion System Value and Market Share by Application (2014-2019)

2.5.3 Global Cardiopulmonary Autotransfusion System Sale Price by Application (2014-2019)

3 Global Cardiopulmonary Autotransfusion System by Players

3.1 Global Cardiopulmonary Autotransfusion System Sales Market Share by Players

3.1.1 Global Cardiopulmonary Autotransfusion System Sales by Players (2017-2019)

3.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Players (2017-2019)

3.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Players

3.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Players (2017-2019)

3.2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Players (2017-2019)

3.3 Global Cardiopulmonary Autotransfusion System Sale Price by Players

3.4 Global Cardiopulmonary Autotransfusion System Manufacturing Base Distribution, Sales Area, Product Types by Players

3.4.1 Global Cardiopulmonary Autotransfusion System Manufacturing Base Distribution and Sales Area by Players

3.4.2 Players Cardiopulmonary Autotransfusion System Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Cardiopulmonary Autotransfusion System by Regions

4.1 Cardiopulmonary Autotransfusion System by Regions

4.1.1 Global Cardiopulmonary Autotransfusion System Consumption by Regions

4.1.2 Global Cardiopulmonary Autotransfusion System Value by Regions

4.2 Americas Cardiopulmonary Autotransfusion System Consumption Growth

4.3 APAC Cardiopulmonary Autotransfusion System Consumption Growth

4.4 Europe Cardiopulmonary Autotransfusion System Consumption Growth

4.5 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Growth

5 Americas

5.1 Americas Cardiopulmonary Autotransfusion System Consumption by Countries

5.1.1 Americas Cardiopulmonary Autotransfusion System Consumption by Countries (2014-2019)

5.1.2 Americas Cardiopulmonary Autotransfusion System Value by Countries (2014-2019)

5.2 Americas Cardiopulmonary Autotransfusion System Consumption by Type

5.3 Americas Cardiopulmonary Autotransfusion System Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Cardiopulmonary Autotransfusion System Consumption by Countries

6.1.1 APAC Cardiopulmonary Autotransfusion System Consumption by Countries (2014-2019)

6.1.2 APAC Cardiopulmonary Autotransfusion System Value by Countries (2014-2019)

6.2 APAC Cardiopulmonary Autotransfusion System Consumption by Type

6.3 APAC Cardiopulmonary Autotransfusion System Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Cardiopulmonary Autotransfusion System by Countries

7.1.1 Europe Cardiopulmonary Autotransfusion System Consumption by Countries (2014-2019)

7.1.2 Europe Cardiopulmonary Autotransfusion System Value by Countries (2014-2019)

7.2 Europe Cardiopulmonary Autotransfusion System Consumption by Type

7.3 Europe Cardiopulmonary Autotransfusion System Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Cardiopulmonary Autotransfusion System by Countries

8.1.1 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption by Countries (2014-2019)

8.1.2 Middle East & Africa Cardiopulmonary Autotransfusion System Value by Countries (2014-2019)

8.2 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption by Type

8.3 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Cardiopulmonary Autotransfusion System Distributors

10.3 Cardiopulmonary Autotransfusion System Customer

11 Global Cardiopulmonary Autotransfusion System Market Forecast

11.1 Global Cardiopulmonary Autotransfusion System Consumption Forecast (2019-2024)

11.2 Global Cardiopulmonary Autotransfusion System Forecast by Regions

11.2.1 Global Cardiopulmonary Autotransfusion System Forecast by Regions (2019-2024)

11.2.2 Global Cardiopulmonary Autotransfusion System Value Forecast by Regions (2019-2024)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.5.6 Spain Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Cardiopulmonary Autotransfusion System Forecast by Type

11.8 Global Cardiopulmonary Autotransfusion System Forecast by Application

12 Key Players Analysis

12.1 Haemonetics

12.1.1 Company Details

12.1.2 Cardiopulmonary Autotransfusion System Product Offered

12.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)

12.1.4 Main Business Overview

12.1.5 Haemonetics News

12.2 Medtronic

12.2.1 Company Details

12.2.2 Cardiopulmonary Autotransfusion System Product Offered

12.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)

12.2.4 Main Business Overview

12.2.5 Medtronic News

12.3 LivaNova

12.3.1 Company Details

12.3.2 Cardiopulmonary Autotransfusion System Product Offered

12.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)

12.3.4 Main Business Overview

12.3.5 LivaNova News

12.4 Fresenius Kabi

12.4.1 Company Details

12.4.2 Cardiopulmonary Autotransfusion System Product Offered

12.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)

12.4.4 Main Business Overview

12.4.5 Fresenius Kabi News

12.5 Terumo

12.5.1 Company Details

12.5.2 Cardiopulmonary Autotransfusion System Product Offered

12.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)

12.5.4 Main Business Overview

12.5.5 Terumo News

12.6 Wandong Health Sources

12.6.1 Company Details

12.6.2 Cardiopulmonary Autotransfusion System Product Offered

12.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)

12.6.4 Main Business Overview

12.6.5 Wandong Health Sources News

...

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Cardiopulmonary Autotransfusion System

Table Product Specifications of Cardiopulmonary Autotransfusion System

Figure Cardiopulmonary Autotrans

Please fill the form below, to recieve the report sample


+1